Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients

Background. Features of nonalcoholic fatty liver disease (NAFLD) have yet to be described in the Canadian First Nations (FN) population. The aim of this study was to compare the prevalence, severity, and outcome of NAFLD in FN versus non-FN patients at an urban, tertiary care centre. Methods. Adults...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia Uhanova, Gerald Minuk, Federico Lopez Ficher, Natasha Chandok
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2016/6420408
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553568270286848
author Julia Uhanova
Gerald Minuk
Federico Lopez Ficher
Natasha Chandok
author_facet Julia Uhanova
Gerald Minuk
Federico Lopez Ficher
Natasha Chandok
author_sort Julia Uhanova
collection DOAJ
description Background. Features of nonalcoholic fatty liver disease (NAFLD) have yet to be described in the Canadian First Nations (FN) population. The aim of this study was to compare the prevalence, severity, and outcome of NAFLD in FN versus non-FN patients at an urban, tertiary care centre. Methods. Adults with NAFLD and no additional liver disease were identified in a prospectively derived database at the University of Manitoba. Demographic, clinical, laboratory, imaging, and histologic data were analyzed. Results. 482 subjects fulfilled diagnostic criteria for NAFLD, including 33 (7%) FN. Aside from rural residence, diabetes and cholestasis being more common in FN patients, the ages, gender distributions, clinical and radiologic features, and liver enzyme/function test results were similar in the two cohorts. Noninvasive tests of fibrosis (APRI and NAFLD fibrosis scores) were also similar in the two cohorts. There were no significant differences in liver enzyme or function tests in either cohort after approximately three years of follow-up. Conclusion. Compared to the prevalence of FN persons in the general population of this study site (10–15%), FN patients were underrepresented in this NAFLD population. The severity and progression of liver disease in FN patients appear to be similar to those in non-FN patients.
format Article
id doaj-art-bbb1457b886a4fa29510b5b9e8340a3f
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-bbb1457b886a4fa29510b5b9e8340a3f2025-02-03T05:53:47ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972016-01-01201610.1155/2016/64204086420408Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations PatientsJulia Uhanova0Gerald Minuk1Federico Lopez Ficher2Natasha Chandok3Section of Hepatology, Department of Internal Medicine, University of Manitoba, 804D-715 McDermot Avenue, Winnipeg, MB, R3E 3P4, CanadaSection of Hepatology, Department of Internal Medicine, University of Manitoba, 804D-715 McDermot Avenue, Winnipeg, MB, R3E 3P4, CanadaSection of Hepatology, Department of Internal Medicine, University of Manitoba, 804D-715 McDermot Avenue, Winnipeg, MB, R3E 3P4, CanadaSection of Hepatology, Department of Internal Medicine, University of Manitoba, 804D-715 McDermot Avenue, Winnipeg, MB, R3E 3P4, CanadaBackground. Features of nonalcoholic fatty liver disease (NAFLD) have yet to be described in the Canadian First Nations (FN) population. The aim of this study was to compare the prevalence, severity, and outcome of NAFLD in FN versus non-FN patients at an urban, tertiary care centre. Methods. Adults with NAFLD and no additional liver disease were identified in a prospectively derived database at the University of Manitoba. Demographic, clinical, laboratory, imaging, and histologic data were analyzed. Results. 482 subjects fulfilled diagnostic criteria for NAFLD, including 33 (7%) FN. Aside from rural residence, diabetes and cholestasis being more common in FN patients, the ages, gender distributions, clinical and radiologic features, and liver enzyme/function test results were similar in the two cohorts. Noninvasive tests of fibrosis (APRI and NAFLD fibrosis scores) were also similar in the two cohorts. There were no significant differences in liver enzyme or function tests in either cohort after approximately three years of follow-up. Conclusion. Compared to the prevalence of FN persons in the general population of this study site (10–15%), FN patients were underrepresented in this NAFLD population. The severity and progression of liver disease in FN patients appear to be similar to those in non-FN patients.http://dx.doi.org/10.1155/2016/6420408
spellingShingle Julia Uhanova
Gerald Minuk
Federico Lopez Ficher
Natasha Chandok
Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
Canadian Journal of Gastroenterology and Hepatology
title Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
title_full Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
title_fullStr Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
title_full_unstemmed Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
title_short Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients
title_sort nonalcoholic fatty liver disease in canadian first nations and non first nations patients
url http://dx.doi.org/10.1155/2016/6420408
work_keys_str_mv AT juliauhanova nonalcoholicfattyliverdiseaseincanadianfirstnationsandnonfirstnationspatients
AT geraldminuk nonalcoholicfattyliverdiseaseincanadianfirstnationsandnonfirstnationspatients
AT federicolopezficher nonalcoholicfattyliverdiseaseincanadianfirstnationsandnonfirstnationspatients
AT natashachandok nonalcoholicfattyliverdiseaseincanadianfirstnationsandnonfirstnationspatients